NASDAQ: MRXMarex Group PLC Stock
$32.92+1.56 (+4.97%)
Updated Mar 14, 2025
MRX Price
$32.92
Fair Value Price
N/A
Market Cap
$2.38B
52 Week Low
$18.13
52 Week High
$40.05
P/E
N/A
P/B
2.43x
P/S
1.41x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.59B
Earnings
$218.00M
Gross Margin
100%
Operating Margin
18.55%
Profit Margin
13.7%
Debt to Equity
23.89
Operating Cash Flow
N/A
Beta
1.07
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MRX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Capital Market
Industry Rating
D
MRX
Ranked#19 of 51
Ranked#19 of 51
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.81 | A | |
| $35.71 | A | |
| $19.48 | B |
Be the first to know about important MRX news, forecast changes, insider trades & much more!
MRX News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MRX is poor value based on its book value relative to its share price (2.43x), compared to the US Capital Markets industry average (2.07x)
P/B vs Industry Valuation
MRX's profit margin has increased (+2.3%) in the last year from (11.4%) to (13.7%)
Profit Margin Growth Financials
MRX's short-term assets ($23.83B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more MRX due diligence checks available for Premium users.
Valuation
MRX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
19.36x
Market
3,446.57x
MRX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.43x
Industry
2.07x
MRX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MRX's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
MRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$24.3B
Liabilities
$23.3B
Debt to equity
23.89
MRX's short-term assets ($23.83B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRX's short-term assets ($23.83B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
MRX vs Capital Market Stocks
Marex Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.